Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Sodium Hyaluronate

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Recruiting1
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03921944Not ApplicableTerminatedPrimary

Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

NCT06154694RecruitingPrimary

Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids

NCT00377624Phase 3CompletedPrimary

HUPS: Hyalgan Use in Painful Shoulder

Showing all 3 trials

Research Network

Common Treatments

  • Sodium Hyaluronate1
  • Stereo Radiographic Eos Measurements1
  • Ct Scan Of The Shoulders1

Active Sponsors

  • Universitaire Ziekenhuizen KU Leuven1
  • Milton S. Hershey Medical Center1
  • Sanofi1

Top Investigators

Activity Timeline